Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.12
(0.83%)
Oil
69.73
0.26%
Bitcoin
97,441.45
3.28%
FTSE 100
8,092.97
0.1%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.09%
Hang Seng
19,601.11
(0.23%)

Next Science Ltd

NXS

ASX

Next Science (NXS) is a medical technology company dedicated to improving human health by combating biofilm-based infections. Their core focus is on the development and commercialization of their proprietary XbioTM technology. Xbio is a unique, non-toxic technology with proven efficacy in eradicating both biofilm-based and free-floating bacteria. By leveraging this innovative technology, NXS aims to revolutionize the treatment of chronic infections and reduce the associated burden on healthcare systems worldwide.

Latest Posts

Line Chart with Gradient
Price
$0.142
0.008 (5.56%)
At Close 20/11 (AEST)
Related Companies
TRIVARX LTD
$TRI
ENLITIC INC.
$ENL
UNIVERSAL BIOSENSORS INC.
$UBI
REGIS HEALTHCARE LIMITED
$REG
MICRO-X LIMITED
$MX1

Leave a Comment on NXS


Comments for NXS

    Latest Posts

    next-science-asx-nxs-enters-into-us5m-unsecured-loan-facility-nxs
    Health Care $NXS

    Next Science (ASX: $NXS) enters into us$5m unsecured loan facility

    Secures additional capital through unsecured loan facility with Thorney Investment Group

    July 17, 2024
    next-science-asx-nxs-completes-sales-restructure-for-cost-savings-nxs
    Health Care $NXS

    Next Science (ASX: $NXS) completes sales restructure for cost savings

    Expects sales growth in 2Q FY24 with improved revenue quality and cashflow positivity

    April 25, 2024
    next-science-asx-nxs-publishes-study-on-blastx-efficacy-in-wound-therapy-nxs
    Health Care $NXS

    Next Science (ASX: $NXS) publishes study on blastx™ efficacy in wound therapy

    Study shows blastx™ effectiveness in treating pressure ulcers with NPWT

    April 9, 2024
    next-science-asx-nxs-reports-strong-fy23-financial-results-nxs
    Health Care $NXS

    Next Science (ASX: $NXS) reports strong FY23 financial results

    Record revenue and operational achievements drive growth in wound care and surgical businesses

    February 28, 2024
    next-science-asx-nxs-publishes-knee-study-showing-anti-inflammatory-potential-for-xperiencetm-nxs
    Health Care $NXS

    Next Science (ASX: $NXS) publishes knee study showing anti-inflammatory potential for XPERIENCETM

    Study demonstrates utility of XPERIENCETM in mitigating inflammation following Total Knee Arthroplasty

    January 14, 2024
    next-science-asxnxs-publishes-knee-study-showing-anti-inflammatory-potential-for-xperiencetm-nxs
    Health Care $NXS

    Next Science (ASX:$NXS) publishes knee study showing anti-inflammatory potential for XPERIENCETM

    Study demonstrates utility of XPERIENCETM in mitigating inflammation following Total Knee Arthroplasty

    December 26, 2023
    next-science-asx-nxs-publishes-new-study-on-infection-prevention-nxs
    Health Care $NXS
    Next Science (ASX: $NXS) publishes new study on infection preventionStudy shows XPERIENCETM's potential in reducing infection rates in knee and hip surgeries

    October 28, 2024

    next-science-asx-nxs-restructures-sales-strategy-impacting-q3-results-nxs
    Health Care $NXS
    Next Science (ASX: $NXS) restructures sales strategy impacting Q3 resultsBiofilm-based infection specialist anticipates future growth despite dip in quarterly sales

    October 22, 2024

    NXS

    $NXS

    Next Science (ASX: $NXS) enters into us$5m unsecured loan facility

    Secures additional capital through unsecured loan facility with Thorney Investment Group

    NXS

    $NXS

    Next Science (ASX: $NXS) completes sales restructure for cost savings

    Expects sales growth in 2Q FY24 with improved revenue quality and cashflow positivity

    NXS

    $NXS

    Next Science (ASX: $NXS) publishes study on blastx™ efficacy in wound therapy

    Study shows blastx™ effectiveness in treating pressure ulcers with NPWT

    NXS

    $NXS

    Next Science (ASX: $NXS) reports strong FY23 financial results

    Record revenue and operational achievements drive growth in wound care and surgical businesses

    NXS

    $NXS

    Next Science (ASX: $NXS) publishes knee study showing anti-inflammatory potential for XPERIENCETM

    Study demonstrates utility of XPERIENCETM in mitigating inflammation following Total Knee Arthroplasty

    NXS

    $NXS

    Next Science (ASX:$NXS) publishes knee study showing anti-inflammatory potential for XPERIENCETM

    Study demonstrates utility of XPERIENCETM in mitigating inflammation following Total Knee Arthroplasty

    Related Companies
    BLINKLAB LIMITED
    $BB1
    LUMOS DIAGNOSTICS HOLDINGS LIMITED
    $LDX
    ARTRYA LIMITED
    $AYA
    OSTEOPORE LIMITED
    $OSX
    ADHERIUM LIMITED
    $ADR

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions